BACKGROUND: Inadequate suppression of renin-angiotensin-aldosterone system (RAAS) following postural maneuvers may have detrimental effects on cardiac structure and function. In this study, we aimed to appraise the clinical significance of this phenomenon by assessing its relation with inappropriate ventricular mass (ILVM), an adverse phenotype of LV remodeling and dysfunction. METHODS: Both supine and upright plasma renin activity (PRA) and aldosterone concentrations (PAC) were measured in 115 young newly diagnosed hypertensive subjects. 24-h ambulatory blood pressure monitoring and echocardiographic evaluation including tissue Doppler imaging (TDI) were also performed. Patients were divided as follows: (1) normal PRA and PAC (N) (n = 63); (2) suppressible RAAS (SR) in supine position (n = 27); (3) not suppressible RAAS (NSR) (n = 25). ILVM was expressed as the observed/predicted LV mass ratio ×100 (%PLVM), while LV dysfunction (LVD) was identified by TDI-derived myocardial performance index (MPI). RESULTS: NSR showed a higher prevalence of ILVM than SR and N. As compared with N and SR, NSR patients had reduced indices of systolic and diastolic function. MPI of the LV as well as prevalence of LVD was also significantly higher in the NSR group. Regression models showed that lack of RAAS suppression was independently associated with ILVM and LVD. CONCLUSIONS: Prevalence of ILVM and LVD is higher in patients without clinostatic RAAS suppression. Our findings encourage the assessment of RAAS deregulation to better estimate individual cardiovascular risk in patients with arterial hypertension.
BACKGROUND: Inadequate suppression of renin-angiotensin-aldosterone system (RAAS) following postural maneuvers may have detrimental effects on cardiac structure and function. In this study, we aimed to appraise the clinical significance of this phenomenon by assessing its relation with inappropriate ventricular mass (ILVM), an adverse phenotype of LV remodeling and dysfunction. METHODS: Both supine and upright plasma renin activity (PRA) and aldosterone concentrations (PAC) were measured in 115 young newly diagnosed hypertensive subjects. 24-h ambulatory blood pressure monitoring and echocardiographic evaluation including tissue Doppler imaging (TDI) were also performed. Patients were divided as follows: (1) normal PRA and PAC (N) (n = 63); (2) suppressible RAAS (SR) in supine position (n = 27); (3) not suppressible RAAS (NSR) (n = 25). ILVM was expressed as the observed/predicted LV mass ratio ×100 (%PLVM), while LV dysfunction (LVD) was identified by TDI-derived myocardial performance index (MPI). RESULTS: NSR showed a higher prevalence of ILVM than SR and N. As compared with N and SR, NSR patients had reduced indices of systolic and diastolic function. MPI of the LV as well as prevalence of LVD was also significantly higher in the NSR group. Regression models showed that lack of RAAS suppression was independently associated with ILVM and LVD. CONCLUSIONS: Prevalence of ILVM and LVD is higher in patients without clinostatic RAAS suppression. Our findings encourage the assessment of RAAS deregulation to better estimate individual cardiovascular risk in patients with arterial hypertension.
Authors: Marina P Okoshi; Xinhua Yan; Katashi Okoshi; Masaharu Nakayama; Adam J T Schuldt; Timothy D O'Connell; Paul C Simpson; Beverly H Lorell Journal: J Card Fail Date: 2004-12 Impact factor: 5.712
Authors: Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Andreas Meinitzer; Bernhard O Boehm; Winfried März Journal: Eur Heart J Date: 2010-03-02 Impact factor: 29.983
Authors: C Tei; K S Dujardin; D O Hodge; K R Bailey; M D McGoon; A J Tajik; S B Seward Journal: J Am Soc Echocardiogr Date: 1996 Nov-Dec Impact factor: 5.251
Authors: G de Simone; R B Devereux; M J Roman; A Ganau; P S Saba; M H Alderman; J H Laragh Journal: J Am Coll Cardiol Date: 1994-05 Impact factor: 24.094
Authors: G de Simone; R B Devereux; A Ganau; R T Hahn; P S Saba; G F Mureddu; M J Roman; B V Howard Journal: Am J Cardiol Date: 1996-10-01 Impact factor: 2.778
Authors: G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman Journal: J Am Coll Cardiol Date: 1992-11-01 Impact factor: 24.094
Authors: V Simopoulos; G Tagarakis; A Hatziefthimiou; I Skoularigis; F Triposkiadis; V Trantou; N Tsilimingas; I Aidonidis Journal: Clin Res Cardiol Date: 2014-08-19 Impact factor: 5.460
Authors: Juan Serrano-Ferrer; Guillaume Walther; Edward Crendal; Agnès Vinet; Frédéric Dutheil; Geraldine Naughton; Bruno Lesourd; Robert Chapier; Daniel Courteix; Philippe Obert Journal: Cardiovasc Diabetol Date: 2014-08-03 Impact factor: 9.951